Call Options

5 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$13.4 - $17.73 $298,820 - $395,379
22,300 New
22,300 $328,000
Q1 2023

May 15, 2023

BUY
$9.09 - $19.45 $909 - $1,945
100 New
100 $1,000
Q4 2019

Feb 14, 2020

SELL
$18.96 - $29.84 $669,288 - $1.05 Million
-35,300 Closed
0 $0
Q3 2019

Nov 14, 2019

SELL
$19.12 - $26.24 $525,800 - $721,600
-27,500 Reduced 43.79%
35,300 $675,000
Q2 2019

Aug 14, 2019

BUY
$19.57 - $24.1 $1.23 Million - $1.51 Million
62,800 New
62,800 $1.38 Million

Others Institutions Holding NEO

About NEOGENOMICS INC


  • Ticker NEO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 125,796,000
  • Market Cap $2.07B
  • Description
  • NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...
More about NEO
Track This Portfolio

Track Walleye Capital LLC Portfolio

Follow Walleye Capital LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Walleye Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Walleye Capital LLC with notifications on news.